Hartley Dylan 4
4 · OnKure Therapeutics, Inc. · Filed Oct 8, 2024
Insider Transaction Report
Form 4
Hartley Dylan
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-10-04+137,603→ 137,603 totalExercise: $18.20Exp: 2034-10-03→ Class A Common Stock (137,603 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on June 9, 2025 and 1/48th of the shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.